Magnetic particle imaging: Principles and clinical application

Nanomedicine - Basic and Clinical Applications in Diagnostics and Therapy

Volumn , Issue , 2011, Pages 88-95

  Buzug, Thorsten M ^a   Sattel, T F ^a   Erbe, M ^a   Biederer, S ^a   Finas, D ^b   Diedrich, K ^b   Vogt, F ^c   Barkhausen, J ^c   Borgert, J ^d   Ludtke Buzug K ^a   Knopp, T ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Clinics for Gynecology   (Germany)

^c Clinic for Radiology and Nuclear Medicine   (Germany)

^d PHILIPS RESEARCH LABORATORIES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMAGE RECONSTRUCTION; INVERSE PROBLEMS; IRON OXIDES; NANOMAGNETICS; NANOPARTICLES;

EXCITATION FREQUENCY; MAGNETIC GRADIENT FIELD; MAGNETIC PARTICLE IMAGING; OSCILLATING MAGNETIC FIELDS; PARTICLE DISTRIBUTIONS; SENTINEL LYMPH NODE BIOPSIES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SYMMETRICAL ARRANGEMENT;

MAGNETIC BUBBLES;

EID: 84908548330     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783805598194.ch7     Document Type: Chapter

References (27)

1. Gleich B, Weizenecker J: Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005;435: 1214-1217.
2. Chikazumi S, Charap SH: Physics of Magnetism. New York, Wiley, 1964.
3. Romanus E, Gross C, Koetitz R, Prass S, Lange J, Weber P, Weitschies W: Monitoring of biological binding reactions by magneto-optical relaxation measurements. Magnetohydrodynamics 2001;37:28-333.
4. Weizenecker J, Borgert J, Gleich B: A simulation study on the resolution and sensitivity of magnetic particle imaging. Phys Med Biol 2007;52:6363-6374.
5. Weaver JB, Rauwerdink AM, Charles R, Sullivan CR, Baker I: Frequency distribution of the nanoparticle magnetization in the presence of a static as well as a harmonic magnetic field. Med Phys 2008;35:1988-1994.
6. Biederer S, Knopp T, Sattel TF, LüdtkeBuzug K, Gleich B, Weizenecker J, Borgert J, Buzug TM: Magnetization response spectroscopy of superparamagnetic nanoparticles for magnetic particle imaging. J Phys D Appl Phys 2009;42:1-7.
7. Lüdtke-Buzug K, Biederer S, Sattel T, Knopp T, Buzug TM: Preparation and Characterization of Dextran-Covered Fe3O4 Nanoparticles for Magnetic Particle Imaging. Proc 4th Eur Congress Med Biomed Eng. IFMBE Ser. Berlin, Springer, 2008, vol 22, pp 2343-2346.
8. Moreland J, Eckstein J, Lin Y, Liou SH, Ruggiero S: Magnetic particle imaging with a cantilever torque magnetometer. 2007. http://meetings.aps.org/link/ BAPS.2007.MAR.U38.10.
9. Goodwill W, Scott C, Stang P, Conolly M: Narrowband magnetic particle imaging. IEEE Trans Med Imaging 2009; 28:1231-1237.
10. Weizenecker J, Gleich B, Borgert J: Magnetic particle imaging using a field-free line. J Phys D Appl Phys 2008; 41:105009
11. Gleich B, Weizenecker J, Borgert J: Experimental results on fast 2D-encoded magnetic particle imaging. Phys Med Biol 2008;53:N81-N84.
12. Sattel TF, Knopp T, Biederer S, Gleich B, Weizenecker J, Borgert J, Buzug TM: Single-sided device for magnetic particle imaging. J Phys D Appl Phys 2009; 42:2-5.
13. Weizenecker J, Gleich B, Rahmer J, Dahnke H, Borgert J: Three-dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 2009; 54:L1-L10.
14. Knopp T, Biederer S, Sattel TF, Weizenecker J, Gleich B, Borgert J, Buzug TM: Trajectory analysis for magnetic particle imaging. Phys Med Biol 2009;56: 385-397.
15. Bulte JW, Gleich B, Weizenecker J, Bernard S, Walczak P, Markov DE, Aerts HC, Borgert J, Boeve H: Developing Cellular MPI: Initial Experience. Berkeley, ISMRM, 2008.
16. Bulte JW, Walczak P, Bernard S, Gleich B, Weizenecker J, Borgert J, Aerts H, Boeve H: Developing Cellular MPI: Initial Experience; in Buzug TM et al (eds): Magnetic Nanoparticles: Particle Science, Imaging Technology, and Clinical Applications. Singapore, World Scientific Publishers, 2010, pp 201-204.
17. Lüdtke-Buzug K, Rapoport D, Schneider D: Characterization of iron-oxide loaded adult stem cells for magnetic particle imaging in targeted cancer therapy; in 8th International Conference on the Scientific and Clinical Applications of Magnetic Carriers. Melville, AIP Conference Proceedings, 2010, 1311, 244-248.
18. Weizenecker J, Gleich B, Rahmer J, Dahnke H, Borgert J: Three-dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 2009; 54:L1-L10.
19. Ruhland B, Baumann K, Knopp T, Sattel TF, Biederer S, Lüdtke-Buzug K, Buzug TM, Diedrich K, Finas D: Magnetic particle imaging with superparamagnetic nanoparticles for sentinel lymph node detection in breast cancer. Geburtshilfe Frauenheilk 2009;69:758.
20. Knopp T, Erbe M, Biederer S, Sattel TF, Buzug TM: Efficient generation of a magnetic field-free line. Med Phys 2010;37:3538-3540.
21. Knopp T, Sattel TF, Biederer S, Buzug TM: Field-free line formation in a magnetic field. J Phys A Math Theor 2010; 43:1-9.
22. Kuehn T, Bembenek A, Decker T, Munz DL, Sautter-Bihl ML, Untch M, Wallwiener D: A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005;103:451-461.
23. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
24. Kühn T, Bembenek A, Büchels H, Decker T, Dunst J, Müllerleile U, Munz DL, Ostertag H, Sautter-Bihl ML, Schirrmeister H, Tulusan AH, Untch M, Winzer KJ, Wittekind C: Sentinel-NodeBiopsie beim Mammakarzinom: interdisziplinär abgestimmter Konsensus der Deutschen Gesellschaft für Senologie für eine qualitätsgesicherte Anwendung in der klinischen Routine. Geburtshilfe Frauenheilk 2003;63:835-840.
25. Robe A, Pic E, Lassalle HP, Bezdetnaya L, Guillemin F, Marchal F: Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice. BMC Cancer 2008;8:111.
26. Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F: A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone. Chin Med J (Engl) 2008;121:1980-1986.
27. Tsunoda N, Kokuryo T, Oda K, Senga T, Yokoyama Y, Nagino M, Nimura Y, Hamaguchi M: Nek2 as a novel molecular target for the treatment of breast carcinoma. Cancer Sci 2009;100:111-116.